BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7532227)

  • 21. Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region.
    Kondo K; Ishii Y; Ochi H; Matsumoto T; Yoshikawa H; Kanda T
    Virology; 2007 Feb; 358(2):266-72. PubMed ID: 17010405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A monoclonal antibody against intact human papillomavirus type 16 capsids blocks the serological reactivity of most human sera.
    Wang Z; Christensen N; Schiller JT; Dillner J
    J Gen Virol; 1997 Sep; 78 ( Pt 9)():2209-15. PubMed ID: 9292008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mapping of human serum-reactive epitopes in virus-like particles of human papillomavirus types 16 and 11.
    Wang X; Wang Z; Christensen ND; Dillner J
    Virology; 2003 Jun; 311(1):213-21. PubMed ID: 12832218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibodies against human papillomavirus type 6 capsids are elevated in men with previous condylomas.
    Wikström A; Eklund C; von Krogh G; Lidbrink P; Dillner J
    APMIS; 1997 Nov; 105(11):884-8. PubMed ID: 9393560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccination of healthy volunteers with human papillomavirus type 16 L2E7E6 fusion protein induces serum antibody that neutralizes across papillomavirus species.
    Gambhira R; Gravitt PE; Bossis I; Stern PL; Viscidi RP; Roden RB
    Cancer Res; 2006 Dec; 66(23):11120-4. PubMed ID: 17145854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of Human Papillomavirus 16-Specific IgG and IgM Antibodies in Patient Sera: A Potential Indicator of Oral Squamous Cell Carcinoma Risk Factor.
    Kerishnan JP; Gopinath SC; Kai SB; Tang TH; Ng HL; Rahman ZA; Hashim U; Chen Y
    Int J Med Sci; 2016; 13(6):424-31. PubMed ID: 27279791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The association of human papillomavirus antibodies with cervical cancer risk.
    Mandelson MT; Jenison SA; Sherman KJ; Valentine JM; McKnight B; Daling JR; Galloway DA
    Cancer Epidemiol Biomarkers Prev; 1992; 1(4):281-6. PubMed ID: 1338895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibodies against linear and conformational epitopes of human papillomavirus type 16 that independently associate with incident cervical cancer.
    Dillner J; Wiklund F; Lenner P; Eklund C; Frederiksson-Shanazarian V; Schiller JT; Hibma M; Hallmans G; Stendahl U
    Int J Cancer; 1995 Jan; 60(3):377-82. PubMed ID: 7530234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum immunoglobulin A response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.
    Viscidi RP; Ahdieh-Grant L; Schneider MF; Clayman B; Massad LS; Anastos KM; Burk RD; Minkoff H; Palefsky J; Levine A; Strickler H
    J Infect Dis; 2003 Dec; 188(12):1834-44. PubMed ID: 14673762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biologic predictors of serologic responses to HPV in oropharyngeal cancer: The HOTSPOT study.
    Anderson KS; Gerber JE; D'Souza G; Pai SI; Cheng JN; Alam R; Kesiraju S; Chowell D; Gross ND; Haddad R; Gillison ML; Posner M
    Oral Oncol; 2015 Aug; 51(8):751-8. PubMed ID: 26094591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seroprevalence of human papillomavirus types 6 and 16 capsid antibodies in homosexual men.
    Hagensee ME; Kiviat N; Critchlow CW; Hawes SE; Kuypers J; Holte S; Galloway DA
    J Infect Dis; 1997 Sep; 176(3):625-31. PubMed ID: 9291307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HPV Serum Antibodies as Predictors of Survival and Disease Progression in Patients with HPV-Positive Squamous Cell Carcinoma of the Oropharynx.
    Dahlstrom KR; Anderson KS; Cheng JN; Chowell D; Li G; Posner M; Sturgis EM
    Clin Cancer Res; 2015 Jun; 21(12):2861-9. PubMed ID: 26078432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study.
    Anantharaman D; Gheit T; Waterboer T; Abedi-Ardekani B; Carreira C; McKay-Chopin S; Gaborieau V; Marron M; Lagiou P; Ahrens W; Holcátová I; Merletti F; Kjaerheim K; Talamini R; Simonato L; Castellsague X; Macfarlane TV; Biggs AM; Thakker N; Znaor A; Thomson P; Canova C; Conway DI; Healy CM; Tommasino M; Pawlita M; Brennan P
    J Natl Cancer Inst; 2013 Apr; 105(8):536-45. PubMed ID: 23503618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salivary and serum HPV antibody levels before and after definitive treatment in patients with oropharyngeal squamous cell carcinoma.
    Hanna GJ; Sridharan V; Margalit DN; La Follette SK; Chau NG; Rabinowits G; Lorch JH; Haddad RI; Tishler RB; Anderson KS; Schoenfeld JD
    Cancer Biomark; 2017; 19(2):129-136. PubMed ID: 28387659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A population-based seroepidemiological study of cervical cancer.
    Dillner J; Lenner P; Lehtinen M; Eklund C; Heino P; Wiklund F; Hallmans G; Stendahl U
    Cancer Res; 1994 Jan; 54(1):134-41. PubMed ID: 8261434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human papillomavirus DNA and antibodies to human papillomaviruses 16 E2, L2, and E7 peptides as predictors of survival in patients with squamous cell cervical cancer.
    Viladiu P; Bosch FX; Castellsagué X; Muñoz N; Escribà JM; Hamsíkova E; Hofmannova V; Guerrero E; Izquierdo A; Navarro C; Moreo P; Izarzugaza I; Ascunce N; Gili M; Muñoz MT; Tafur L; Shah KV; Vonka V
    J Clin Oncol; 1997 Feb; 15(2):610-9. PubMed ID: 9053484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human papillomavirus DNA load and p16INK4a expression predict for local control in patients with anal squamous cell carcinoma treated with chemoradiotherapy.
    Rödel F; Wieland U; Fraunholz I; Kitz J; Rave-Fränk M; Wolff HA; Weiss C; Wirtz R; Balermpas P; Fokas E; Rödel C
    Int J Cancer; 2015 Jan; 136(2):278-88. PubMed ID: 24839133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seroepidemiologic studies of bovine papillomavirus infections.
    Pfister H; Huchthausen B; Gross G; zur Hausen H
    J Natl Cancer Inst; 1979 Jun; 62(6):1423-5. PubMed ID: 220453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of anal epidermoid cancer-related viruses on the dendritic (Langerhans') cells of the human anal mucosa.
    Sobhani I; Walker F; Aparicio T; Abramowitz L; Henin D; Cremieux AC; Soule JC
    Clin Cancer Res; 2002 Sep; 8(9):2862-9. PubMed ID: 12231528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A survey of seroprevalence of human papillomavirus types 16, 18 and 33 among children.
    af Geijersstam V; Eklund C; Wang Z; Sapp M; Schiller JT; Dillner J; Dillner L
    Int J Cancer; 1999 Feb; 80(4):489-93. PubMed ID: 9935145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.